First human test for new diabetes drug begins
NCT ID NCT07223333
Summary
This is the first study testing a new drug called PATAS in humans. Researchers want to see if single injections are safe and how the drug moves through the body. The study involves 56 healthy volunteers who will receive either the drug or a placebo. The goal is to gather initial safety data to see if PATAS can be developed further as a treatment for Type 2 Diabetes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Medpace Clinical Pharmacology Unit
RECRUITINGCincinnati, Ohio, 45227, United States
Contact
-
Medpace Clinical Pharmaology Unit
RECRUITINGCincinnati, Ohio, 45227, United States
Conditions
Explore the condition pages connected to this study.